Privacy during epidemic of COVID-19: a bibliometric analysis

1226 articles on privacy and COVID-19 were published by authors from 69 countries in this year's issue. COVID 19's privacy is now the focus of many researchers' attention. The present body of knowledge on privacy for COVID-19 digital technologies has been thoroughly analyzed, and a concise overview of research status and future developments can be gleaned. This paper conducted a bibliometric examination of privacy using the Scopus dataset. Utilizing VOSviewer software, the relevant literature papers published on this topic were examined to determine the field's development history, research hotspots, and future directions. Over time, there has been a rise in the number of studies published in privacy for COVID-19, particularly after 2020, and the growth rate has been steadily increasing. Regarding published research, the United States and China lead the pack. These articles appeared in primarily English-language journals and conference proceedings. Privacy and COVID-19 research was mostly computer science. The most used terms in privacy and COVID-19 were data privacy and humans. This paper examines the evolution of privacy and COVID-19 research and indicates current research priorities and future research goals. Furthermore, the privacy and COVID-19 study seem to be a promising sphere as this study identifies 26 domains. © 2023, Institute of Advanced Engineering and Science. All rights reserved.

Privacy during epidemic of COVID-19: a bibliometric analysis

1226 articles on privacy and COVID-19 were published by authors from 69 countries in this year's issue. COVID 19's privacy is now the focus of many researchers' attention. The present body of knowledge on privacy for COVID-19 digital technologies has been thoroughly analyzed, and a concise overview of research status and future developments can be gleaned. This paper conducted a bibliometric examination of privacy using the Scopus dataset. Utilizing VOSviewer software, the relevant literature papers published on this topic were examined to determine the field's development history, research hotspots, and future directions. Over time, there has been a rise in the number of studies published in privacy for COVID-19, particularly after 2020, and the growth rate has been steadily increasing. Regarding published research, the United States and China lead the pack. These articles appeared in primarily English-language journals and conference proceedings. Privacy and COVID-19 research was mostly computer science. The most used terms in privacy and COVID-19 were data privacy and humans. This paper examines the evolution of privacy and COVID-19 research and indicates current research priorities and future research goals. Furthermore, the privacy and COVID-19 study seem to be a promising sphere as this study identifies 26 domains. © 2023, Institute of Advanced Engineering and Science. All rights reserved.

Neutralizing antibody responses to SARS-CoV-2: A population based seroepidemiological analysis.

This study (August-September 2021) estimated the seroprevalence of SARS-CoV-2 neutralizing antibodies in the general population of Delhi and correlated it with their anti-SARS-CoV-2 IgG levels. Samples were selected by simple random sampling method. The neutralizing capacity was estimated by performing a surrogate virus neutralization test (sVNT) (GenScript), Piscataway, NJ, USA. A total of 2233 (87.1%, 95% C.I. 85.7, 88.3) of the 2564 SARS-CoV-2 IgG seropositive samples had detectable SARS-CoV-2 neutralizing antibodies. In samples with S/CO â€‹≥ â€‹4.00, the neutralizing antibodies ranged from 94.5% to 100%. The SARS-CoV-2 neutralizing antibody seroprevalence strongly correlated with the S/CO range of IgG SARS-CoV-2 (r â€‹= â€‹0.62, p â€‹= â€‹0.002).

Study of COVID-19 Infection, its Severity and Outcome in COVID-19 Vaccinated People at Tertiary Health Care Center, North West Rajasthan

OBJECTIVE: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of corona virus-induced disease 19 (COVID-19) that was declared as a global pandemic in March 2020 by the world health organization (WHO). Two vaccines were granted for emergency use by the Central Drugs Standard Control Organization (CDSCO) in India, Covishield® (AstraZeneca's vaccine manufactured by Serum Institute of India) and Covaxin® (manufactured by Bharat Biotech Limited). Sputnik - V has been granted EUA in the month of April 2021. The purpose of this study is to determine the association of COVID-19 infection, its severity and outcome in COVID-19 vaccinated people. METHODS: This was a hospital based prospective cohort study done between March to June 2021 at PBM Associated Group of Hospitals (AGH), Bikaner, Raj. Total 1028 COVID suspected cases consulted in COVID OPD or hospitalized under department of medicine, out of which 146 satisfied the inclusion and exclusion criteria, out of these 146, first 100 cases who gave consent for part of study were selected. RESULTS: Among 100 COVID-19 infected cases, 49 received first dose while rest got both doses. After first dose of vaccination 42.86% had mild and 32.65% had severe clinical infection while after both doses 80.39% had mild and 11.76% had severe clinical infection. On evaluation of HRCT Chest, after first dose 8.16% had normal 40.82% were in severe category while those who got both doses it was 52.82% 3.92% respectively. Among 49 who got first dose, 10.20% recovered on just home based treatment without any need of hospitalization, while 89.8% got admitted in dedicated COVID hospital out of which 73.47% got recovered and 16.33% died. Among 51 who got both the doses, 66.67% recovered on just home based treatment, while 33.33% required hospitalization out of which 25.49% got recovered and 7.84% died. CONCLUSION: After 2nd dose of vaccine there is a significant risk reduction in need of hospitalization and getting severe infection and mortality when compared with first dose only. © Journal of the Association of Physicians of India 2011.

Cyber-criminology defense in pervasive environment: A study of cybercrimes in Malaysia

The growth of technologies;infrastructures and platforms with less or no security protection in emerging big data and internet of things (IoT) trends increase the likelihood of cybercrime attacks. With the rise of coronavirus disease-2019 (Covid-19) pandemic towards mankind, more cybercrimes are designed to penetrate one’s cognitive mind in revealing sensitive details. In this paper;an exploration of cybercrime threats in Southeast Asia country;Malaysia from year 2008 up to 2020 and its hike trends and impacts will be discussed. An investigation revolving the study of cyber-criminology and the reasoning behind the growth in terms of technological advancement will be presented. The findings suggest that the consequences and impacts of the cyberspace attacks are beyond the loss of money and reputations. It now becomes the failure of the global systemic altogether. As a mechanism to handle this would be to focus on protecting mission critical applications in pervasive environment. In this paper, a comprehensive authentication and authorization framework in safeguarding applications and users in the pervasive environment will be presented. © 2021, Institute of Advanced Engineering and Science. All rights reserved.

Study of COVID-19 infection, its severity and outcome in COVID-19 vaccinated people at tertiary health care center, north west Rajasthan

Objective: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of corona virus-induced disease 19 (COVID-19) that was declared as a global pandemic in March 2020 by the world health organization (WHO). Two vaccines were granted for emergency use by the Central Drugs Standard Control Organization (CDSCO) in India, Covishield® (AstraZeneca’s vaccine manufactured by Serum Institute of India) and Covaxin® (manufactured by Bharat Biotech Limited). Sputnik - V has been granted EUA in the month of April 2021. The purpose of this study is to determine the association of COVID-19 infection, its severity and outcome in COVID-19 vaccinated people. Methods: This was a hospital based prospective cohort study done between March to June 2021 at PBM & Associated Group of Hospitals (AGH), Bikaner, Raj. Total 1028 COVID suspected cases consulted in COVID OPD or hospitalized under department of medicine, out of which 146 satisfied the inclusion and exclusion criteria, out of these 146, first 100 cases who gave consent for part of study were selected. Results: Among 100 COVID-19 infected cases, 49 received first dose while rest got both doses. After first dose of vaccination 42.86% had mild and 32.65% had severe clinical infection while after both doses 80.39% had mild and 11.76% had severe clinical infection. On evaluation of HRCT Chest, after first dose 8.16% had normal & 40.82% were in severe category while those who got both doses it was 52.82% & 3.92% respectively. Among 49 who got first dose, 10.20% recovered on just home based treatment without any need of hospitalization, while 89.8% got admitted in dedicated COVID hospital out of which 73.47% got recovered and 16.33% died. Among 51 who got both the doses, 66.67% recovered on just home based treatment, while 33.33% required hospitalization out of which 25.49% got recovered and 7.84% died. Conclusion: After 2nd dose of vaccine there is a significant risk reduction in need of hospitalization and getting severe infection and mortality when compared with first dose only. © 2021 Journal of Association of Physicians of India. All rights reserved.

Knowledge, attitude and practices towards covid-19 among undergraduate students in a medical college of delhi

Background: Medical students play an important role in the prevention and control of COVID-19 by way of disseminating knowledge regarding COVID-19 among the people. It is affected by their knowledge, attitude and practices about the disease. Objectives: To assess the knowledge, attitudes, and practices (KAP) towards COVID-19 in undergraduate medical students. Methodology: A quick online survey was carried out among 316 participants with a self-designed, structured questionnaire in the form of goggle form. Cronbach’s alpha of the study instrument was 0.71. Statistical Analysis: Data were analyzed by SPSS, version 25. Chi-square test, Student’s t-test, ANOVA and post hoc analysis were done. Results: A total of 316 participants completed the survey questionnaire. The mean COVID-19 knowledge scorewas 18.82±2.27 and overall 90% had correct knowledge. Knowledge scores significantly (p<0.05) differed across age-groups and semesters. In post hoc analysis, mean knowledge score in 2nd semester students (18.11±2.55) was significantly (p<0.05) lower than that of 8th semester (19.56±1.66). Seventy percent respondents agreed that COVID-19 will finally be controlled,77.2% had confidence that India will win the battle against COVID-19, and 90% of the respondents agreed that hand washing with soap water will prevent them from getting the infection. 96.2% participants avoid crowded places, 95.2% participants wore face masks while going outside home and 97.5%frequently washed hands with soap and water. Conclusion: In this study majority undergraduate students had good knowledge, showed optimistic attitude and appropriate practice towards COVID-19. However, there is need and scope for improving knowledge and practices so that every student adopts preventive and promotive measures against COVID-19.

Telemedicine: Embracing virtual care during COVID-19 pandemic.

Telemedicine and related e-health facilities facilitate care from a distance through electronic information systems. COVID-19 pandemic is establishing telemedicine in the health care delivery system of countries. Telehealth is contributing significantly in health care delivery during the COVID-19 crisis. For mild-to-moderate symptoms of COVID-19 or any illness, telehealth services might represent a better, efficient way to receive initial care and perform triaging. Telemedicine also has a significant role in screening for COVID-19 symptoms and delivering routine needs and follow-up care. The large-scale adoption of telemedicine in public health care delivery is still not visible in low- and middle-income countries like India. Adoption by patients and healthcare professionals is limited and their concerns need to be addressed to ensure its utilization in future of the care continuum. In the current paper, we aim to review recent measures of Telemedicine adopted during the course of pandemic and its impact on public health in lower-middle income countries like India.